Related Experiment Videos
Editorial for the special Issue "Jörg Steinbach"
1Institut für Radiopharmazeutische Krebsforschung, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.
Journal of Labelled Compounds & Radiopharmaceuticals
|May 30, 2019
Summary
This special issue honors Jörg Steinbach, a pioneer in radiopharmaceutical chemistry and cancer research. His retirement marks the end of an era in innovative radiopharmaceutical development.
Area of Science:
- Radiopharmaceutical Chemistry
- Bioinorganic Chemistry
- Cancer Research
Background:
- Commemorates the scientific contributions of Jörg Steinbach.
- Highlights his roles as Director of the Institute of Radiopharmaceutical Cancer Research at HZDR and Professor at TU Dresden.
- Notes his retirement coinciding with legal changes and the inauguration of a new research center.
Discussion:
- Celebrates Professor Steinbach's legacy in advancing radiopharmaceutical science.
- Underscores the importance of his leadership in cancer research.
- Recognizes the transition in leadership at the Institute of Radiopharmaceutical Cancer Research.
Key Insights:
- Professor Steinbach's work has significantly impacted the field of radiopharmaceuticals.
- His research has contributed to advancements in cancer diagnostics and therapeutics.
- The establishment of the new Centre for Radiopharmaceutical Tumor Research signifies continued progress.
Outlook:
- The special issue serves as a tribute to Professor Steinbach's enduring influence.
- It anticipates future innovations in radiopharmaceutical cancer research.
- It marks a new chapter for the Institute and the broader field.